Loading...
•
Mar 31, 2024
Oncology Institute Q1 2024 Earnings Report
The Oncology Institute reported strong revenue growth and reduced SG&A expenses.
Key Takeaways
The Oncology Institute (TOI) reported a 24.2% increase in consolidated revenue, reaching $95 million for Q1 2024. The company signed seven new capitation and value-based contracts across three states. Despite revenue growth, gross profit decreased by 15.1% year-over-year to $12 million. Net loss improved to $19.9 million compared to $30.0 million in the prior year quarter. The company reaffirms its full year 2024 guidance.
Consolidated revenue increased by 24.2% to $95 million compared to the prior year quarter.
Gross profit decreased by 15.1% to $12 million compared to the prior year quarter.
Net loss decreased to $19.9 million compared to $30.0 million for the prior year quarter.
The company signed 7 new capitation and value-based contracts across 3 states.
Revenue by Segment
Forward Guidance
TOI reaffirms its full year 2024 guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...